# A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

> **NCT06630429** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 100 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer
- Renal Cell Carcinoma (RCC)

## Interventions

- **OTHER:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT06630429
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-02
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06630429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06630429, "A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06630429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*